🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, single-arm, open study to observe the efficacy and s...
Status
Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2024-10-15
Trial ID
NCT06589089
Treatments Being Tested
This phase I trial studies the side effects and best dose of genetically mo...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2013-10-08
Trial ID
NCT01815749
An open follow up study of patients enrolled in the Phase 1/2 clinical tria...
Status
Active Not Recruiting
Location
Hopital Necker - Enfants Malades
Start Date
2014-09
Trial ID
NCT02333760
Treatments Being Tested
This study aims to recover ovarian function in POF/POI patients. With this ...
Status
Unknown
Location
Hospital Universitario y Politécnico la Fe-IIS la Fe
Start Date
2018-06
Trial ID
NCT03535480
RATIONALE: Giving high-dose chemotherapy drugs, such as carmustine, etoposi...
Status
Completed
Location
City of Hope Medical Center
Start Date
2000-05-10
Trial ID
NCT00641381
This is a Phase I multi-center study to evaluate the safety of FT596 when g...
Status
Completed
Location
University of Minnesota
Start Date
2020-09-22
Trial ID
NCT04555811
RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT00550784
Randomized study of autologous un-manipulated peripheral blood hematopoieti...
Status
Terminated
Location
Northwestern University
Start Date
2017-11-08
Trial ID
NCT03342638
Treatments Being Tested
The purpose of this trial is to develop an alternative treatment for patien...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2007-01
Trial ID
NCT00481832
The primary objective of this study is to evaluate the safety of gemtuzumab...
Status
Completed
Location
Multiple Locations
Start Date
2000-03
Trial ID
NCT00044733
Treatments Being Tested